These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 38276535)
1. Botulinum Toxin Versus Placebo: A Meta-Analysis of Treatment and Quality-of-life Outcomes for Hyperhidrosis. Obed D; Salim M; Bingoel AS; Hofmann TR; Vogt PM; Krezdorn N Aesthetic Plast Surg; 2021 Aug; 45(4):1783-1791. PubMed ID: 33619611 [TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin and hyperhidrosis of the amputation stump in war amputees. Mouhli N; Hfaidh M; Abdennadher A; Ben Amor K; Rahali H; Amri K; Maaoui R Tunis Med; 2024 Apr; 102(4):200-204. PubMed ID: 38746958 [TBL] [Abstract][Full Text] [Related]
4. Internalized stigma, disease severity, quality of life, anxiety and depression in axillary hyperhidrosis. Gökşin Ş; İmren IG Ann Dermatol Venereol; 2024 Jul; 151(3):103291. PubMed ID: 39013257 [TBL] [Abstract][Full Text] [Related]
5. The reliability and validity of a developed anxiety scale specific to primary focal hyperhidrosis symptoms. Ogawa S; Tayama J; Murota H; Kobayashi M; Kinoshita H; Nakamichi S Biopsychosoc Med; 2024 Jun; 18(1):14. PubMed ID: 38835082 [TBL] [Abstract][Full Text] [Related]
8. Impact of Systemic Treatments on Outcomes and Quality of Life in Patients with RAS-Positive Stage IV Colorectal Cancer: A Systematic Review. Braicu V; Stelian P; Fulger L; Verdes G; Brebu D; Duta C; Fizedean C; Ignuta F; Danila AI; Cozma GV Diseases; 2024 Apr; 12(4):. PubMed ID: 38667537 [TBL] [Abstract][Full Text] [Related]
9. Intradermal Botulinum Toxin A Injection Versus Topical 2% Glycopyrrolate for the Treatment of Primary Facial Hyperhidrosis: A Pilot Study and Review of Literature. Nofal E; Salem S; Khashaba SA Dermatol Surg; 2022 Aug; 48(8):843-848. PubMed ID: 35917265 [TBL] [Abstract][Full Text] [Related]
10. Facial hyperhidrosis: best practice recommendations and special considerations. Glaser DA; Hebert AA; Pariser DM; Solish N Cutis; 2007 May; 79(5 Suppl):29-32. PubMed ID: 17596098 [TBL] [Abstract][Full Text] [Related]
11. Longitudinal Assessment of Facial Hyperhidrosis Management: Evaluating the Utility and Quality of Life Improvements following Botulinum Toxin Injection. Prodan-Barbulescu C; Castiglione L; Burtic SR; Murariu M; Reddy S; Rosca O; Bratosin F; Melania Fizedean C; Krupyshev P; Enatescu I Toxins (Basel); 2024 Jan; 16(1):. PubMed ID: 38276535 [TBL] [Abstract][Full Text] [Related]
12. Assessing Botulinum Toxin Effectiveness and Quality of Life in Axillary Hyperhidrosis: A One-Year Prospective Study. Castiglione L; Murariu M; Boeriu E; Enatescu I Diseases; 2024 Jan; 12(1):. PubMed ID: 38248366 [TBL] [Abstract][Full Text] [Related]
13. Botulinum Toxin Type A for Treatment of Forehead Hyperhidrosis: Multicenter Clinical Experience and Review from Literature. Campanati A; Martina E; Gregoriou S; Kontochristopoulos G; Paolinelli M; Diotallevi F; Radi G; Bobyr I; Marconi B; Gualdi G; Amerio P; Offidani A Toxins (Basel); 2022 May; 14(6):. PubMed ID: 35737033 [TBL] [Abstract][Full Text] [Related]
14. C-Arm Guided Percutaneous Radiofrequency Thoracic Sympathectomy for Treatment of Primary Palmar Hyperhidrosis in Comparison with Local Botulinum Toxin Type A Injection, Randomized Trial. Mostafa TAH; Hamed AA; Mohammed BM; El Sheikh NA; Shama AAA Pain Physician; 2019 Nov; 22(6):591-599. PubMed ID: 31775406 [TBL] [Abstract][Full Text] [Related]
15. A comparative study between intradermal botulinum toxin A and fractional microneedle radiofrequency (FMR) for the treatment of primary axillary hyperhidrosis. Rummaneethorn P; Chalermchai T Lasers Med Sci; 2020 Jul; 35(5):1179-1184. PubMed ID: 31939036 [TBL] [Abstract][Full Text] [Related]